Who are Silvadene's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Trimethoprim, Azo Gantanol, Azo Gantrisin, Sulfamylon® For 5 % Topical Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/silvadene.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Silvadene — Competitive Intelligence Brief

Silvadene (Silver Sulfadiazine) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: sulfonamide antimicrobial. Area: Infectious Disease.

marketed sulfonamide antimicrobial bacterial cell membrane and cell wall Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Silvadene (Silver Sulfadiazine) — Pfizer. Silver sulfadiazine acts on bacterial cell membrane and cell wall to produce bactericidal effect.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Silvadene TARGET	Silver Sulfadiazine	Pfizer	marketed	sulfonamide antimicrobial	bacterial cell membrane and cell wall	1973-01-01
Trimethoprim	TRIMETHOPRIM	Dr Reddys Labs Sa	marketed	Sulfonamide Antimicrobial [EPC]	Dihydrofolate reductase	1973-01-01
Azo Gantanol	SULFAMETHOXAZOLE	Pfizer	marketed	Sulfonamide Antimicrobial [EPC]		1973-01-01
Azo Gantrisin	sulfafurazole	Alra	marketed	Sulfonamide Antimicrobial	Endothelin-1 receptor	1971-01-01
Sulfamylon® For 5 % Topical Solution	Sulfamylon® For 5 % Topical Solution	Mylan Inc.	marketed	Sulfonamide antimicrobial agent	Dihydropteroate synthase (bacterial folate synthesis pathway)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (sulfonamide antimicrobial class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silvadene — Competitive Intelligence Brief. https://druglandscape.com/ci/silvadene. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab